An efficacy study of RHB-104 in newly diagnosed and the treatment-naïve Crohn's disease patients.

Trial Profile

An efficacy study of RHB-104 in newly diagnosed and the treatment-naïve Crohn's disease patients.

Planning
Phase of Trial: Phase II/III

Latest Information Update: 27 Oct 2016

At a glance

  • Drugs Clarithromycin/clofazimine/rifabutin (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2016 New trial record
    • 07 Oct 2016 According to a RedHill media release this study along with other study (CTP-700277881) will provide additional supportive clinical data to potential future marketing applications.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top